Related Experiment Video
Updated: Apr 12, 2026

12:05
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
12.6K
Rare cytogenetic abnormalities in myelodysplastic syndromes
Ulrike Bacher1, Julie Schanz1, Friederike Braulke1
1Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
Summary
This review highlights rare chromosomal abnormalities in myelodysplastic syndromes (MDS). Integrating these rare findings into prognostication systems like the IPSS-R requires international collaboration for better patient outcomes.
Area of Science:
- Hematology
- Cytogenetics
- Oncology
Background:
- Karyotype is crucial for prognostication in myelodysplastic syndromes (MDS) using systems like IPSS and IPSS-R.
- Common cytogenetic abnormalities in MDS are well-studied, but rare abnormalities require further investigation.
Purpose of the Study:
- To review and highlight selected rare cytogenetic abnormalities in MDS.
- To emphasize the need for integrating these rare findings into existing prognostication systems.
Main Methods:
- Literature review focusing on rare cytogenetic abnormalities in MDS.
- Analysis of prognostic impact of specific numerical and structural chromosomal changes.
Main Results:
- Identified rare abnormalities such as gains of chromosomes 11, 14, 21, loss of X chromosome, and del(13q).
- These abnormalities have varying prognostic implications, from rapid progression to favorable responses.
Conclusions:
- Rare cytogenetic abnormalities in MDS are important and should be incorporated into prognostication models like IPSS-R.
- International collaboration is essential to gather sufficient data on rare abnormalities for accurate prognostication.
Related Concept Videos
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Karyotyping
70.4K
Overview
70.4K
Karyotyping
12.1K
12.1K
Induced Pluripotent Stem Cells
6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
6.3K
Nondisjunction
83.8K
During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
83.8K
Nondisjunction
5.9K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
5.9K

